Cargando…

Inhibitors of CLK Protein Kinases Suppress Cell Growth and Induce Apoptosis by Modulating Pre-mRNA Splicing

Accumulating evidence has demonstrated the importance of alternative splicing in various physiological processes, including the development of different diseases. CDC-like kinases (CLKs) and serine-arginine protein kinases (SRPKs) are components of the splicing machinery that are crucial for exon se...

Descripción completa

Detalles Bibliográficos
Autores principales:	Araki, Shinsuke, Dairiki, Ryo, Nakayama, Yusuke, Murai, Aiko, Miyashita, Risa, Iwatani, Misa, Nomura, Toshiyuki, Nakanishi, Osamu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4291223/ https://www.ncbi.nlm.nih.gov/pubmed/25581376 http://dx.doi.org/10.1371/journal.pone.0116929

Ejemplares similares

Synergistic apoptotic effects in cancer cells by the combination of CLK and Bcl-2 family inhibitors
por: Murai, Aiko, et al.
Publicado: (2020)

Anti‐tumor efficacy of a novel CLK inhibitor via targeting RNA splicing and MYC‐dependent vulnerability
por: Iwai, Kenichi, et al.
Publicado: (2018)

CLK-dependent exon recognition and conjoined gene formation revealed with a novel small molecule inhibitor
por: Funnell, Tyler, et al.
Publicado: (2017)

SGC-CLK-1: A chemical probe for the Cdc2-like kinases CLK1, CLK2, and CLK4
por: Tiek, Deanna, et al.
Publicado: (2023)

Targeting pre-mRNA splicing in cancers: roles, inhibitors, and therapeutic opportunities
por: Araki, Shinsuke, et al.
Publicado: (2023)

Stress-responsive maturation of Clk1/4 pre-mRNAs promotes phosphorylation of SR splicing factor
por: Ninomiya, Kensuke, et al.
Publicado: (2011)

Specific CLK Inhibitors from a Novel Chemotype for Regulation of Alternative Splicing
por: Fedorov, Oleg, et al.
Publicado: (2011)

Phosphorylation of the alternative mRNA splicing factor 45 (SPF45) by Clk1 regulates its splice site utilization, cell migration and invasion
por: Liu, Yuying, et al.
Publicado: (2013)

Clk/STY (cdc2-Like Kinase 1) and Akt Regulate Alternative Splicing and Adipogenesis in 3T3-L1 Pre-Adipocytes
por: Li, Pengfei, et al.
Publicado: (2013)

CLK2 blockade modulates alternative splicing compromising MYC‐driven breast tumors
por: Salvador, Fernando, et al.
Publicado: (2018)

Pharmacological inhibition of CLK2 activates YAP by promoting alternative splicing of AMOTL2
por: Bulos, Maya L., et al.
Publicado: (2023)

Controlling clots with Clk1
por: Williams, Ruth
Publicado: (2006)

Hypoxia leads to significant changes in alternative splicing and elevated expression of CLK splice factor kinases in PC3 prostate cancer cells
por: Bowler, Elizabeth, et al.
Publicado: (2018)

CLK1/CLK2-driven signalling at the Leishmania kinetochore is captured by spatially referenced proximity phosphoproteomics
por: Geoghegan, Vincent, et al.
Publicado: (2022)

Gene regulatory network analysis defines transcriptome landscape with alternative splicing of human umbilical vein endothelial cells during replicative senescence
por: Ohori, Momoko, et al.
Publicado: (2021)

Targeting the trypanosome kinetochore with CLK1 protein kinase inhibitors
por: Saldivia, Manuel, et al.
Publicado: (2020)

Development of an In Vitro Chloroplast Splicing System: Sequences Required for Correct pre-mRNA Splicing
por: Inaba-Hasegawa, Keiko, et al.
Publicado: (2021)

CLK-2/TEL2 is a conserved component of the nonsense-mediated mRNA decay pathway
por: Guo, Yanwu, et al.
Publicado: (2021)

HGG-21. ABERRANT SPLICING OF CLK1 IN PEDIATRIC HIGH-GRADE GLIOMAS DISRUPTS KEY ONCOGENIC TRANSCRIPTIONAL PROGRAMS
por: Naqvi, Ammar, et al.
Publicado: (2023)

Benzobisthiazoles Represent a Novel Scaffold for Kinase Inhibitors of CLK Family Members
por: Prak, Krisna, et al.
Publicado: (2015)

Kinase Domain Insertions Define Distinct Roles of CLK Kinases in SR Protein Phosphorylation
por: Bullock, Alex N., et al.
Publicado: (2009)

Drug Discovery of Host CLK1 Inhibitors for Influenza Treatment
por: Zu, Mian, et al.
Publicado: (2015)

Pre-mRNA Splicing in the Nuclear Landscape
por: Carrocci, Tucker J., et al.
Publicado: (2020)

Dibenzofuran Derivatives Inspired from Cercosporamide as Dual Inhibitors of Pim and CLK1 Kinases
por: Dao, Viet Hung, et al.
Publicado: (2021)

Opposing roles of CLK SR kinases in controlling HIV-1 gene expression and latency
por: Dahal, Subha, et al.
Publicado: (2022)

Targeting CLK3 inhibits the progression of cholangiocarcinoma by reprogramming nucleotide metabolism
por: Zhou, Qingxin, et al.
Publicado: (2020)

Disruption of pre-mRNA splicing in vivo results in reorganization of splicing factors
Publicado: (1994)

NSrp70 is a novel nuclear speckle-related protein that modulates alternative pre-mRNA splicing in vivo
por: Kim, Young-Dae, et al.
Publicado: (2011)

RNA catalyzes nuclear pre-mRNA splicing
por: Fica, Sebastian M., et al.
Publicado: (2013)

Pre-mRNA splicing-associated diseases and therapies
por: Love, Sierra L., et al.
Publicado: (2023)

Prediction of alternative pre-mRNA splicing outcomes
por: Najjar, Rayan, et al.
Publicado: (2023)

Amplification-free whole-genome bisulfite sequencing by post-bisulfite adaptor tagging
por: Miura, Fumihito, et al.
Publicado: (2012)

CLK2 Expression Is Associated with the Progression of Colorectal Cancer and Is a Prognostic Biomarker
por: Lin, Jiarui, et al.
Publicado: (2022)

Differential Recruitment of Pre-mRNA Splicing Factors to Alternatively Spliced Transcripts In Vivo
por: Mabon, Stephen A, et al.
Publicado: (2005)

U1-independent pre-mRNA splicing contributes to the regulation of alternative splicing
por: Fukumura, Kazuhiro, et al.
Publicado: (2009)

Synergistic anti-AML effects of the LSD1 inhibitor T-3775440 and the NEDD8-activating enzyme inhibitor pevonedistat via transdifferentiation and DNA rereplication
por: Ishikawa, Y, et al.
Publicado: (2017)

Correction: Synergistic anti-AML effects of the LSD1 inhibitor T-3775440 and the NEDD8-activating enzyme inhibitor pevonedistat via transdifferentiation and DNA rereplication
por: Ishikawa, Y., et al.
Publicado: (2019)

Differential effect of CLK SR Kinases on HIV-1 gene expression: potential novel targets for therapy
por: Wong, Raymond, et al.
Publicado: (2011)

Structure Activity Relationship Studies around DB18, a Potent and Selective Inhibitor of CLK Kinases
por: Brahmaiah, Dabbugoddu, et al.
Publicado: (2022)

MicroRNA-Biogenesis and Pre-mRNA Splicing Crosstalk
por: Shomron, Noam, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_p2nsgbqjqfecjrfi613umrimlc